Wednesday, July 20, 2016 10:31:00 AM
Of course, it may not amount to the nearly 20% of the current O/S after the 1:30,000 R/S that's planned. Unless, there's an anti dilution clause attached to them. But I doubt that since 8687544 Canada Inc is to receive 30,000,000 shares after the R/S for the supposed rights title and interest in the Injex needle.
Of course, it may all be moot if 8687544 Canada doesn't actually have the rights to the Injex needle as they claim.
Hopefully, that'll be cleared up shortly.
You can lead a horse to water. But you can't make him get down on one knee and do an Al Jolson impression!
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM